Teachers Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Teachers Advisors’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$243K	Hold	39,252	–	–	﹤0.01%	2802
2018 Q4	$132K	Buy	39,252 +3,074	+8%	+$14.4K	﹤0.01%	2928
2018 Q3	$235K	Sell	36,178 -260	-0.7%	-$1.93K	﹤0.01%	2890
2018 Q2	$279K	Buy	36,438 +10,896	+43%	+$157K	﹤0.01%	2892
2018 Q1	$571K	Hold	25,542	–	–	﹤0.01%	2471
2017 Q4	$326K	Buy	25,542 +9,507	+59%	+$140K	﹤0.01%	2756
2017 Q3	$250K	Buy	16,035 +4,804	+43%	+$67.9K	﹤0.01%	2917
2017 Q2	$158K	Buy	11,231 +2,347	+26%	+$50.2K	﹤0.01%	3040
2017 Q1	$195K	Buy	+8,884	New	+$188K	﹤0.01%	2882

Other funds holding JNCE

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Teachers Advisors's JNCE Position: Q1 2019 in Review

Teachers Advisors held its Jounce Therapeutics, Inc. Common Stock (JNCE) position steady in Q1 2019 at 39,252 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #2802.

Teachers Advisors first reported a position in JNCE in Q1 2017 and has held it in 9 quarters since. The position peaked at $571K in Q1 2018. 80 funds tracked by Wall St. Rank hold JNCE as of Q1 2019.

Teachers Advisors held 39,252 shares of Jounce Therapeutics, Inc. Common Stock worth $243K as of Q1 2019.
Teachers Advisors left its Jounce Therapeutics, Inc. Common Stock share count unchanged in Q1 2019.
Jounce Therapeutics, Inc. Common Stock made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2802 holding.
Teachers Advisors first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2017 and has held it in 9 quarters since.
Teachers Advisors's Jounce Therapeutics, Inc. Common Stock position peaked at $571K in Q1 2018.
80 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.